Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
Urologic Oncology
|
May 21, 2026
Impact of intraoperative intravenous heparin bolus on clinical outcomes during radical nephrectomy and IVC tumor thrombectomy in renal cell carcinoma with level I-IV IVC thrombus: A multi-institutional study
Ahmet Murat Aydin, Alireza Dehghanmanshadi, Vaneeza Mukhtar, et al.
European Urology Focus
|
September 13, 2018
The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy
Charles C Peyton, E Jason Abel, Juan Chipollini, et al.
Scientific Reports
|
March 1, 2019
Serum Polyunsaturated Fatty Acids Correlate with Serum Cytokines and Clinical Disease Activity in Crohn's Disease
Elizabeth A Scoville, Margaret M Allaman, Dawn W Adams, et al.
Journal of Clinical Microbiology
|
August 30, 2001
Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results
B Van Der Pol, D H Martin, J Schachter, et al.
Urology
|
August 12, 2020
Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma
Leo D Dreyfuss, Viraj A Master, Jay D Raman, et al.
Clinical Genitourinary Cancer
|
November 9, 2017
Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration
Juan Chipollini, E Jason Abel, Charles C Peyton, et al.
Plos One
|
March 28, 2020
Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease: A pilot study
Elizabeth A Scoville, Hilary A Tindle, Quinn S Wells, et al.
Minerva Urology and Nephrology
|
May 20, 2026
Survival outcomes after cytoreductive nephrectomy with tumor thrombectomy: results from the Intercontinental Collaboration on Renal Cell Carcinoma
Maxwell Sandberg, Gregory Russell, Phillip Krol, et al.
The Lancet. Oncology
|
August 30, 2025
TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trial
Andrea Necchi, Félix Guerrero-Ramos, Paul L Crispen, et al.
Cancers
|
November 13, 2025
Comparing Cytoreductive Nephrectomy with Tumor Thrombectomy Between Open, Laparoscopic, and Robotic Approaches
Maxwell Sandberg, Gregory Russell, Phillip Krol, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
Urologic Oncology
|
May 21, 2026
Impact of intraoperative intravenous heparin bolus on clinical outcomes during radical nephrectomy and IVC tumor thrombectomy in renal cell carcinoma with level I-IV IVC thrombus: A multi-institutional study
Ahmet Murat Aydin, Alireza Dehghanmanshadi, Vaneeza Mukhtar, et al.
European Urology Focus
|
September 13, 2018
The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy
Charles C Peyton, E Jason Abel, Juan Chipollini, et al.
Scientific Reports
|
March 1, 2019
Serum Polyunsaturated Fatty Acids Correlate with Serum Cytokines and Clinical Disease Activity in Crohn's Disease
Elizabeth A Scoville, Margaret M Allaman, Dawn W Adams, et al.
Journal of Clinical Microbiology
|
August 30, 2001
Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results
B Van Der Pol, D H Martin, J Schachter, et al.
Urology
|
August 12, 2020
Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma
Leo D Dreyfuss, Viraj A Master, Jay D Raman, et al.
Clinical Genitourinary Cancer
|
November 9, 2017
Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration
Juan Chipollini, E Jason Abel, Charles C Peyton, et al.
Plos One
|
March 28, 2020
Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease: A pilot study
Elizabeth A Scoville, Hilary A Tindle, Quinn S Wells, et al.
Minerva Urology and Nephrology
|
May 20, 2026
Survival outcomes after cytoreductive nephrectomy with tumor thrombectomy: results from the Intercontinental Collaboration on Renal Cell Carcinoma
Maxwell Sandberg, Gregory Russell, Phillip Krol, et al.
The Lancet. Oncology
|
August 30, 2025
TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trial
Andrea Necchi, Félix Guerrero-Ramos, Paul L Crispen, et al.
Cancers
|
November 13, 2025
Comparing Cytoreductive Nephrectomy with Tumor Thrombectomy Between Open, Laparoscopic, and Robotic Approaches
Maxwell Sandberg, Gregory Russell, Phillip Krol, et al.
Page
of 14